[1]
Schlesinger, T., Kircik, L., Armstrong, A., Berman, B., Bhatia, N., Del Rosso, J., Lebwohl, M., Patel, V., Rigel, D., Narayanan, S., Koscielny, V. and Kasujee, I. 2023. Investigator Global assessment (IGA) of Actinic Keratosis (AK) among patients administered tirbanibulin in real-world community practices across the U.S., and clinician likelihood to consider tirbanibulin again for future AK treatments (PROAK Study). SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s162. DOI:https://doi.org/10.25251/skin.7.supp.162.